Literature DB >> 35959476

Revisiting the single-eyelid hughes reconstruction - A report of two cases.

Spencer Harris1, Rona Z Silkiss1.   

Abstract

Purpose: The reconstruction of near-total upper eyelid defects is challenging and complicated. There are multiple possible techniques, including multi-stage lower eyelid flaps (such as Mustarde's lid-switch flap and the Cutler-Beard techniques) as well as single-stage techniques with free grafts. Here we present two patients requiring near-total upper eyelid repairs that were accomplished by a single-eyelid, single-stage technique using a tarsoconjunctival flap. Observations: Two cases of near-total upper eyelid defects are described, one secondary to resection of a basal cell carcinoma and the other secondary to resection of a Merkel cell carcinoma. Both cases had sufficient residual tarsus to supply a single-eyelid tarsoconjunctival flap. Results were excellent. Conclusions: When there is sufficient tarsus remaining, the illustrated technique provides an excellent repair of near-total upper-eyelid defects. It is a simpler procedure than its alternatives, spares other tissue sites, eliminates free grafts, and does not require multiple stages.
© 2022 Published by Elsevier Inc.

Entities:  

Keywords:  Modified hughes; Total eyelid defect reconstruction

Year:  2022        PMID: 35959476      PMCID: PMC9358419          DOI: 10.1016/j.ajoc.2022.101667

Source DB:  PubMed          Journal:  Am J Ophthalmol Case Rep        ISSN: 2451-9936


Introduction/background

Reconstructing large eyelid defects can be complicated, as it is crucial to maintain the support of the tarsus to maintain eyelid shape, stability, and function. Historically, Mustarde's lid-switch flap and the Cutler-Beard techniques have been used for large upper eyelid defect repairs., Since their introduction, multiple variations have been proposed which use different compositions of flaps and tarsus. All of these techniques use lower eyelid tissue to reconstruct the upper eyelid defect. Multiple single-stage techniques have been proposed for large eyelid defect reconstruction. These techniques usually use a myocutaneous flap for the anterior lamella with a rigid graft to replace the missing tarsus (creating a posterior lamella), such as cartilage (chondromucosal, buccal mucosa, hard palate, or auricular sources), sclera from eye banks, or tarsus from the lower lid or contralateral upper lid. For these techniques, the rigid graft (no matter the source) is a “free graft.” An alternative to using free grafts to recreate the posterior lamella is the use of a regional flap (reverse auricular, chondromucosal island, pericranial, and periosteal flaps). In 1989, Jordan et al. described a technique using a tarsoconjunctival flap from the same eyelid as the defect for reconstruction of the posterior lamella (recessing levator and Mueller's muscle to free the flap) and then a myocutaneous eyelid flap to reconstruct the anterior lamella. Irvine et al. replicated this technique with good results in 2003, and in 2014 Malik et al. described a modified technique used for smaller eyelid defects where they rotated the tarsoconjunctival flap obliquely. In our literature review, additional reports utilizing this method were not identified. We present two cases of eyelid reconstruction using this technique with a myocutaneous flap and posterior approach Mueller's muscle and levator aponeurosis recession with excellent outcomes.

Findings

Case 1, Basal Cell Carcinoma. An 87-year-old woman with a biopsy-proven basal cell carcinoma underwent surgical excision with frozen sections and lid reconstruction. After achieving adequate excision with negative margins (1 mm of clear margin was obtained, verified on both permanent and frozen section analysis), the full thickness defect involved approximately 95% of the upper eyelid margin, though the defect was only 4 mm in vertical height and did not involve the punctum. The upper eyelid was everted over a Desmarres retractor. Vertical incisions made with a #15 Bard Parker blade freed the conjunctiva and tarsus superior to the defect. This tissue was dissected as possible from overlying Mueller's muscle and levator aponeurosis. Both structures were recessed to avoid postoperative eyelid retraction. This created a Hughes-type eyelid pedicle flap containing the residual superior tarsus. The flap was mobilized inferiorly into the upper eyelid defect and sutured to the remaining upper eyelid tissue surrounding the original defect. The anterior lamella was then created using a sliding transposition flap of skin. The orbicularis was dissected from underlying orbital septum and advanced to aid in the blood supply and aesthetics of the reconstruction. Postoperatively, the cosmetic result was pleasing. There was no lagophthalmos. See Fig. 1 for visualization of each step and post-operative results. It has now been 6 months since surgery and the patient has no recurrence, retraction, or corneal surface complications.
Fig. 1

Case 1 with basal cell carcinoma excision. A.) Appearance after excision, involving nearly the entire upper eyelid. B.) Creation of the tarsal-conjunctival pedicle flap. C.) Mobilized flap positioned into the defect. D.) Pedicle and myocutaneous flap sutured in place. E.) Appearance post-operative week 1. F.) Appearance post-operative week 1 with eyes closed.

Case 1 with basal cell carcinoma excision. A.) Appearance after excision, involving nearly the entire upper eyelid. B.) Creation of the tarsal-conjunctival pedicle flap. C.) Mobilized flap positioned into the defect. D.) Pedicle and myocutaneous flap sutured in place. E.) Appearance post-operative week 1. F.) Appearance post-operative week 1 with eyes closed. Case 2: Merkel cell carcinoma. An 83-year-old male with Merkel cell carcinoma required resection of the upper eyelid to achieve clear margins. The same technique as described above was employed, with excellent results. See Fig. 2. This case was completed 10 years ago and is still without recurrence, retraction, or corneal surface complications.
Fig. 2

Case 2 with Merkel cell carcinoma excision. A.) Appearance pre-operatively. B.) Resultant large upper eyelid defect following excision. C.) Preparation of tarsal-conjunctival flap, levator aponeurosis, orbicularis and cutaneous flap. D.) Post reconstructive appearance intraoperatively.

Case 2 with Merkel cell carcinoma excision. A.) Appearance pre-operatively. B.) Resultant large upper eyelid defect following excision. C.) Preparation of tarsal-conjunctival flap, levator aponeurosis, orbicularis and cutaneous flap. D.) Post reconstructive appearance intraoperatively.

Discussion/conclusion

Total or near-total eyelid reconstruction is complex, and current surgical techniques have limitations and drawbacks. While multi-stage repairs work well, they require that the eye be completely occluded until the second surgery is completed (usually two weeks later at the earliest). Single-stage techniques eliminate the occlusion problem, however grafts, especially those that utilize donor tissue may have complications including graft failure or necrosis, albeit uncommonly. Leibovitch et al. found that free tarsal grafts have fewer complications than hard palate grafts, though most complications were temporary. The technique illustrated here is both single-stage and single-eyelid. It provides an identical tissue match and eliminates the need for a free graft, thus simplifying the procedure and sparing other tissue sites. There are limitations to such a repair. The defect to be reconstructed must be less than 7 mm in vertical height (assuming a 10 mm tarsal height) to allow for at least 3 mm of remaining tarsus to ensure eyelid stability, and the patient must have sufficient eyelid laxity/redundant tissue to allow for a myocutaneous flap. However, when the defect/anatomy fits these parameters, this technique is an excellent choice and should be considered due to its simplicity, efficiency, safety, and excellent outcomes.

Patient consent

Consent to publish the case report was not obtained. This report does not contain any personal information that could lead to the identification of the patient.

Funding

No funding was received for this work.

Authorship

We confirm that the manuscript has been read and approved by all named authors. We confirm that the order of authors listed in the manuscript has been approved by all named authors.

Declaration of competing interest

No conflict of interest exists.

Intellectual property

We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property.

Research ethics

We further confirm that any aspect of the work covered in this manuscript that has involved human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. IRB approval was obtained (required for studies and series of 3 or more cases) Written consent to publish potentially identifying information, such as details or the case and photographs, was obtained from the patient(s) or their legal guardian(s).

Contact with the editorial office

This author submitted this manuscript using his/her account in EVISE. We understand that this Corresponding Author is the sole contact for the Editorial process (including EVISE and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that the email address shown below is accessible by the Corresponding Author, is the address to which Corresponding Author's EVISE account is linked, and has been configured to accept email from the editorial office of American Journal of Ophthalmology Case Reports: spencerharrisophthalmology@gmail.com. Someone other than the Corresponding Author declared above submitted this manuscript from his/her account in EVISE: We understand that this author is the sole contact for the Editorial process (including EVISE and direct communications with the office). He/she is responsible for communicating with the other authors, including the Corresponding Author, about progress, submissions of revisions and final approval of proofs.
  10 in total

1.  A method for partial and total upper lid reconstruction.

Authors:  N L CUTLER; C BEARD
Journal:  Am J Ophthalmol       Date:  1955-01       Impact factor: 5.258

Review 2.  New horizons in eyelid reconstruction.

Authors:  J C Mustardé
Journal:  Int Ophthalmol Clin       Date:  1989

3.  Techniques and outcomes of total upper and lower eyelid reconstruction.

Authors:  Jean-Louis deSousa; Igal Leibovitch; Raman Malhotra; Brett O'Donnell; Tim Sullivan; Dinesh Selva
Journal:  Arch Ophthalmol       Date:  2007-12

4.  Sliding tarsal advancement flap for upper eyelid reconstruction.

Authors:  Adeela Malik; Sabrina Shah-Desai
Journal:  Orbit       Date:  2014-01-16

Review 5.  Revascularization studies of an opposing eyelid pedicle flap.

Authors:  R Z Silkiss; B J Glasgow; H I Baylis
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1989       Impact factor: 1.746

6.  Tarsoconjunctival flap for upper eyelid reconstruction.

Authors:  D R Jordan; R L Anderson; T S Nowinski
Journal:  Arch Ophthalmol       Date:  1989-04

7.  Tarsal-conjunctival advancement flaps for upper eyelid reconstruction.

Authors:  C R Leone
Journal:  Arch Ophthalmol       Date:  1983-06

Review 8.  Posterior lamellar reconstruction: a comprehensive review of the literature.

Authors:  Alessandra Fin; Fabrizio De Biasio; Paolo Lanzetta; Sebastiano Mura; Anna Tarantini; Pier Camillo Parodi
Journal:  Orbit       Date:  2018-05-21

9.  A technique for reconstruction of upper lid marginal defects.

Authors:  F Irvine; A A McNab
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

10.  Hard palate and free tarsal grafts as posterior lamella substitutes in upper lid surgery.

Authors:  Igal Leibovitch; Raman Malhotra; Dinesh Selva
Journal:  Ophthalmology       Date:  2006-03       Impact factor: 12.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.